A detailed history of Waypoint Capital Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Waypoint Capital Advisors, LLC holds 4,520 shares of DHR stock, worth $1.04 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
4,520
Previous 4,478 0.94%
Holding current value
$1.04 Million
Previous $1.12 Million 12.34%
% of portfolio
0.31%
Previous 0.29%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$239.25 - $280.76 $10,048 - $11,791
42 Added 0.94%
4,520 $1.26 Million
Q2 2024

Jul 25, 2024

BUY
$235.51 - $267.98 $17,898 - $20,366
76 Added 1.73%
4,478 $1.12 Million
Q1 2024

Apr 30, 2024

SELL
$224.58 - $256.19 $1,796 - $2,049
-8 Reduced 0.18%
4,402 $1.1 Million
Q4 2023

Jan 22, 2024

SELL
$185.1 - $233.13 $25,543 - $32,171
-138 Reduced 3.03%
4,410 $1.02 Million
Q3 2023

Oct 25, 2023

BUY
$233.08 - $265.59 $3,263 - $3,718
14 Added 0.31%
4,548 $1.13 Million
Q2 2023

Jul 13, 2023

SELL
$224.99 - $256.14 $2,474 - $2,817
-11 Reduced 0.24%
4,534 $1.09 Million
Q1 2023

Apr 13, 2023

SELL
$239.75 - $277.0 $78,638 - $90,856
-328 Reduced 6.73%
4,545 $1.15 Million
Q4 2022

Jan 23, 2023

BUY
$241.42 - $282.29 $5,311 - $6,210
22 Added 0.45%
4,873 $0
Q3 2022

Oct 17, 2022

SELL
$247.06 - $1507.4 $46,447 - $283,391
-188 Reduced 3.73%
4,851 $1.25 Million
Q2 2022

Jul 18, 2022

BUY
$237.11 - $299.66 $9,484 - $11,986
40 Added 0.8%
5,039 $1.28 Million
Q1 2022

Apr 19, 2022

BUY
$257.27 - $315.76 $51,968 - $63,783
202 Added 4.21%
4,999 $1.47 Million
Q4 2021

Feb 07, 2022

BUY
$292.08 - $329.01 $1.4 Million - $1.58 Million
4,797 New
4,797 $1.58 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Waypoint Capital Advisors, LLC Portfolio

Follow Waypoint Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waypoint Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waypoint Capital Advisors, LLC with notifications on news.